These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8958597)

  • 21. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.
    Dalack GW; Healy DJ; Meador-Woodruff JH
    Am J Psychiatry; 1998 Nov; 155(11):1490-501. PubMed ID: 9812108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.
    Allen MH; Debanné M; Lazignac C; Adam E; Dickinson LM; Damsa C
    Am J Psychiatry; 2011 Apr; 168(4):395-9. PubMed ID: 21245085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking and schizophrenia.
    Sagud M; Mihaljević-Peles A; Mück-Seler D; Pivac N; Vuksan-Cusa B; Brataljenović T; Jakovljević M
    Psychiatr Danub; 2009 Sep; 21(3):371-5. PubMed ID: 19794359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of nicotine: fact or fiction?
    Richmond R
    Addiction; 1994 Feb; 89(2):139-40; discussion 144-6. PubMed ID: 8173476
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cigarette smoking and sleep disturbance].
    Underner M; Paquereau J; Meurice JC
    Rev Mal Respir; 2006 Jun; 23(3 Suppl):6S67-6S77. PubMed ID: 16820750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales.
    West R; Ussher M; Evans M; Rashid M
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):619-27. PubMed ID: 16308727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smoking in schizophrenia: recent findings about an old problem.
    Sagud M; Mihaljevic Peles A; Pivac N
    Curr Opin Psychiatry; 2019 Sep; 32(5):402-408. PubMed ID: 31135490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neural mechanisms underlying nicotine dependence.
    Balfour DJ
    Addiction; 1994 Nov; 89(11):1419-23. PubMed ID: 7841851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine use in schizophrenia and disinhibition.
    Dervaux A; Baylé FJ; Laqueille X; Bourdel MC; Le Borgne MH; Olié JP; Krebs MO
    Psychiatry Res; 2004 Oct; 128(3):229-34. PubMed ID: 15541779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking cessation leads to reduced stress, but why?
    Parrott AC
    Int J Addict; 1995 Sep; 30(11):1509-16. PubMed ID: 8530219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of acute smoking on brain activity vary with abstinence in smokers performing the N-Back task: a preliminary study.
    Xu J; Mendrek A; Cohen MS; Monterosso J; Simon S; Brody AL; Jarvik M; Rodriguez P; Ernst M; London ED
    Psychiatry Res; 2006 Dec; 148(2-3):103-9. PubMed ID: 17088048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoke, smoke, smoke that cigarette.
    Keltner NL; Grant JS
    Perspect Psychiatr Care; 2006 Nov; 42(4):256-61. PubMed ID: 17107571
    [No Abstract]   [Full Text] [Related]  

  • 34. Nicotine and familial vulnerability to schizophrenia: a discordant twin study.
    Lyons MJ; Bar JL; Kremen WS; Toomey R; Eisen SA; Goldberg J; Faraone SV; Tsuang M
    J Abnorm Psychol; 2002 Nov; 111(4):687-93. PubMed ID: 12428784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
    George TP; Ziedonis DM; Feingold A; Pepper WT; Satterburg CA; Winkel J; Rounsaville BJ; Kosten TR
    Am J Psychiatry; 2000 Nov; 157(11):1835-42. PubMed ID: 11058482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine deprivation attenuates panic reactivity in smokers: Findings from a placebo-controlled nicotine patch study.
    Abrams K; Krimmel S; Johnson S; Cieslowski K; Strnad H; Melum A; Kryder C
    Depress Anxiety; 2017 Nov; 34(11):996-1005. PubMed ID: 28489321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
    Cerimele JM; Durango A
    J Clin Psychiatry; 2012 Aug; 73(8):e1039-47. PubMed ID: 22967780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking.
    Levin ED; Westman EC; Stein RM; Carnahan E; Sanchez M; Herman S; Behm FM; Rose JE
    J Clin Psychopharmacol; 1994 Feb; 14(1):41-9. PubMed ID: 8151002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotine, negative affect, and depression.
    Hall SM; Muñoz RF; Reus VI; Sees KL
    J Consult Clin Psychol; 1993 Oct; 61(5):761-7. PubMed ID: 7902368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult attention-deficit/hyperactivity disorder and nicotine withdrawal: a qualitative study of patient perceptions.
    Liebrenz M; Fisher CE; Nellen R; Frei A; Biechl AC; Hiestand N; Huber A; Buadze A; Eich D
    BMC Psychiatry; 2016 Jul; 16():208. PubMed ID: 27377376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.